Doxorubicin Liposomal - NDC Database
3 records found
Page:
0338-0080 Aug 15, 2019
Doxorubicin Hydrochloride Liposome Liposome 2 mg/ml Intravenous Injection, Suspension, Liposomal by Baxter Healthcare Corporation
Doxorubicin Hydrochloride Liposome Liposome 2 mg/ml Intravenous Injection, Suspension, Liposomal by Baxter Healthcare Corporation
0338-0086 Aug 15, 2019
Doxorubicin Hydrochloride Liposome Liposome 2 mg/ml Intravenous Injection, Suspension, Liposomal by Baxter Healthcare Corporation
Doxorubicin Hydrochloride Liposome Liposome 2 mg/ml Intravenous Injection, Suspension, Liposomal by Baxter Healthcare Corporation
59676-966 Jun 26, 2017
Doxorubicin Hydrochloride Liposome Liposome 2 mg/ml Intravenous Injection, Suspension, Liposomal by Janssen Products, Lp
Doxorubicin Hydrochloride Liposome Liposome 2 mg/ml Intravenous Injection, Suspension, Liposomal by Janssen Products, Lp
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.